Treatment of Pediatric Low-Grade Gliomas

被引:0
作者
Sameer Farouk Sait
Alexandra M. Giantini-Larsen
Kathryn R. Tringale
Mark M. Souweidane
Matthias A. Karajannis
机构
[1] Memorial Sloan Kettering Cancer Center,Department of Pediatrics
[2] Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College,Department of Neurosurgery
[3] Memorial Sloan Kettering Cancer Center,Department of Radiation Oncology
来源
Current Neurology and Neuroscience Reports | 2023年 / 23卷
关键词
Pediatric low-grade gliomas; Glioneuronal tumors; Neurosurgery; Chemotherapy; Radiotherapy; Molecular targeted therapy; MEK inhibitors; BRAF inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:185 / 199
页数:14
相关论文
共 713 条
[1]  
Louis DN(2021)The 2021 WHO classification of tumors of the central nervous system: a summary Neuro Oncol 23 1231-51
[2]  
Perry A(2011)Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group Neurosurgery 68 1548-54
[3]  
Wesseling P(2014)Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database Pediatr Blood Cancer 61 1173-9
[4]  
Brat DJ(2017)Pediatric low-grade gliomas: implications of the biologic era Neuro Oncol 19 750-761
[5]  
Cree IA(2008)BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas J Clin Invest 118 1739-1749
[6]  
Figarella-Branger D(2013)Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas Nat Genet 45 602-612
[7]  
Wisoff JH(2020)Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas Cancer Cell 37 569-83.e5
[8]  
Sanford RA(2015)Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape J Clin Oncol 33 2986-2998
[9]  
Heier LA(2018)Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the Children’s Oncology Group Randomized ACNS0332 Trial J Clin Oncol 36 JCO2017764720-678
[10]  
Sposto R(2015)Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers Acta Neuropathol 129 669-22